Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Keywords MINIMAL RESIDUAL DISEASE

Publicaciones

Citas Totales

Autores Afiliación Chile

Instituciones Chile


Disciplinas de Investigación




Muestra la distribución de publicaciones, con dominio Chile desde 2008, en las cuales se ha utilizado el keyword seleccionado.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.


WoS #Pub
Oncology 9
Urology & Nephrology 7
Hematology 4
Surgery 2
Gastroenterology & Hepatology 2
Medicine, General & Internal 1
Immunology 1
Biochemistry & Molecular Biology 1
Medical Laboratory Technology 1

Scopus #Pub
Oncology 7
Cancer Research 7
Urology 2
Medicine (All) 1
Structural Biology 1
Biochemistry 1

SciELO #Pub
Health Sciences 1

Autores Chile


Nombre Género #Pub
MURRAY-MCCLURE, NIGEL PETER Hombre 23
AEDO, SOCRATES - 14
SALAZAR, ANIBAL Hombre 13
REYES-MORAGA, EDUARDO FELIPE Hombre 13
FUENTEALBA-SUDY, CYNTHIA ALEJANDRA Mujer 12
GUZMAN, EGHON - 9
ORREGO, SHENDA - 9
MINZER, SIMONA Mujer 7
CAMPBELL-BULLA, MYRIAM Mujer 6
VILLALON, RICARDO Hombre 6
ANTONIO LOPEZ, MARCO Hombre 2
MARINOV, NEDA Mujer 2
ORREGO, SHENDA - 1
SANTIBANEZ, JUAN F. Hombre 1
ROA, JUAN CARLOS Hombre 1
LOPEZ, MARCO ANTONIO Hombre 1
ALBARRAN, VIDAL Hombre 1
ORREGO, SHENDA - 1
GUZMAN, EGHON - 1
FUENTEALBA, CINTHIA Mujer 1
FUENTEALBA, CINTHIA Mujer 1
GUZMAN, EGHON - 1
CONTRERAS, LUIS Hombre 1
SANCHEZ DEL VILLAR, MATIAS - 1
HOPKINS, CHRISTINE ROJAS - 1
AEDO, SOCRATES - 1
RODRIGUEZ, PATRICIA MARIA Mujer 1
HARTMANN, DAN - 1
RODRIGUEZ, MARIA PATRICIA Mujer 1
HARTMANN, DAN - 1
MURRAY, NIGEL P. Hombre 1
BOROWITZ, MICHAEL Hombre 1
MELO-ANGERMEYER, ANGELICA SOLEDAD Mujer 1
ARZENO, LUCAS Hombre 1
ANTONIO LOPEZ, MARCO Hombre 1
JACOB, OMAR Hombre 1
GUZMAN-MALUENDA, LEDA MARCELA Mujer 1
RAMIREZ-VILLANUEVA, PABLO ANTONIO Hombre 1
GARRIDO-CONTRERAS, MABELIN Hombre 1
ROA, IVAN Hombre 1
GALINDO, HECTOR Hombre 1
AGUILERA, SERGIO Hombre 1
CASTILLO, D. Hombre 1
ORELLANA, ERIC Hombre 1
RISUENO-ALVAREZ, CONCEPCION - 1
RAMÍREZ V, PABLO Hombre 1
ALVAREZ Z, MANUEL Hombre 1
ARTIGAS A, CARMEN GLORIA Mujer 1
PÁEZ F, EDUARDO Hombre 1
VITTINI DE R, CECILIA Mujer 1
ARRIAGADA M, MÓNICA Mujer 1
GONZÁLEZ O, LUIS Hombre 1
PFLAUMER F, ERNA Mujer 1
LOPEZ, MARCO ANTONIO Hombre 1
LÓPEZ, MARCO ANTONIO Hombre 1
MUÑOZ, LORENA Mujer 1
LÓPEZ, MARCO ANTONIO Hombre 1
REYES, EDUARDO Hombre 1

Listado ordenado de autores con afiliación Chile que han utilizado el keyword seleccionado en publicaciones con dominio Chile desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.



Distribución por género de autores que han utilizado el keyword seleccionado en publicaciones WoS con dominio Chile desde 2008.

Es importante mencionar que si no se encuentra el nombre del autor en el diccionario (que está en permanente actualización) este no se contabiliza y su género es Indeterminado.

Porcentaje Indeterminados: 22.4 % del total de autores

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Instituciones Chile



Distribución de Universidades Chilenas que han utilizado el keyword seleccionado en publicaciones con dominio Chile desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Institución #Pub
Universidad Finis Terrae 23
Hospital de Carabineros 21
Hospital Direccion de Prevision de Carabineros de Chile 11
Universidad Diego Portales 10
Universidad Mayor 7
Universidad de Chile 5
Facultad de Medicina 2
Hospital de Niños Roberto del Río 2
Programa Infantil Nacional de Drogas Antineoplásicas 1
Instituto de Salud Pública de Chile 1
Universidad Nacional Andrés Bello 1
Chilean Natl Pediat Oncol Grp PINDA 1
Programa Infantil Nacl Drogas Antineoplas 1
Hospital de Niños Robeto del Rio 1
Hosp Roberto Del Rio 1
Chilean National Pediatric Oncology Group 1
School of Medicine Finis Terrae and San Sebastian Universities 1
Universidad Bernardo O'Higgins 1
Universidad de Los Andes, Chile 1
Hospital Roberto del Río 1
HOSP REG TEMUCO 1
Inst Salud Publ Chile 1
Pontificia Universidad Católica de Valparaíso 1
Universidad de Valparaíso 1
Universidad de La Frontera 1
Clínica Alemana 1
Pontificia Universidad Católica de Chile 1

Publicaciones


Título Año Citas
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse 2019 8
Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer 2019 0
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy 2019 8
Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study 2017 2
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 2018 58
Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer 2017 9
How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome 2017 3
Bone marrow microenvironment in chronic myeloid leukemia: Implications for disease physiopathology and response to treatment 2014 3
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002 2014 165
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study 2010 99
Polymerase chain reaction (PCR) detection of B cell clonality in Sjogren's syndrome patients: a diagnostic tool of clonal expansion 2010 15
Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer 2008 2
Detection of BCR-ABL gene sequences using polymerase chain reaction-reverse transcriptase in patients with leukemia 2002 5
Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer 2019 4
Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer CÉlulas prostÁticas circulantes y micro-metÁstasis en mÉdula Ósea determinantes en el riesgo y en el tiempo de progresiÓn bioquÍmica en cÁncer prostÁtico localizado 2019 0
Minimum residual disease in patients post radical prostatectomy for prostate cancer: Theoretical considerations, clinical implications and treatment outcome 2018 0
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy 2020 2
Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study 2020 4
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy 2020 1
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy 2020 1
Minimal residual disease and not the treatment predicts biochemical recurrence in patients with low-risk prostate cancer La enfermedad mínima residual y no el tratamiento predice la recidiva bioquímica en sujetos con cáncer prostático de bajo riesgo 2019 0
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alonePalabras claves 2021 5
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone 2020 1
Immune dysfunction, minimal residual disease and patient outcome in nonmetastatic cancer: could modulation of immune function improve outcome? 2021 0
Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone 2021 0
CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy 2021 0
CAPRA score vs subtypes of minimal residual disease as predictors of biochemical recurrence after radical prostatectomy la puntuación capra frente a los subtipos de enfermedad residual mínima para predecir la recidiva bioquímica después de la prostatectomía radical 2021 0
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report 2021 14
Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome 2021 1
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium 2022 16
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome 2022 0
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and-MM4 trials 2023 6
Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer 2022 0
Expert Recommendations for the Diagnosis, Treatment, and Management of Adult B-Cell Acute Lymphoblastic Leukemia in Latin America 2023 0
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-MUnster 2009 Trial 2023 2
The role of matrix metalloproteinase-2 in the metastatic cascade: a review 2024 0
Biomarkers of minimal residual disease and treatment 2024 0

Listado ordenado de publicaciones con dominio Chile que han utilizado el keyword seleccionado desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Localización regional de las publicaciones con dominio Chile que han utilizado el keyword seleccionado desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Descargar Descarga los datos de esta página (formato JSON).
Descargar Descarga los datos de esta página como un archivo Excel.









Departamento Gestión de Conocimiento, Monitoreo y Prospección
 Moneda 1375, Santiago de Chile. Teléfono (56 2) 2365 4400
Consultas o comentarios: productividad@anid.cl